IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion
IMPRESS
1 other identifier
interventional
784
1 country
1
Brief Summary
The goal of this Hybrid Type 2 Implementation-Effectiveness Cluster Randomised Controlled Trial is to reduce the treatment gap for depression through the integrated implementation of interventions in facility and community platforms, in Goa, India. The primary question is to examine whether a community intervention ("Community Model") enhances the demand for, and improves the outcomes of, an evidence-based, brief psychological treatment for depression delivered by non-specialist health workers in primary health care facilities ("Facility Model"). Participants in the Facility Model arm will receive only a psychosocial intervention for depression (the Healthy Activity Program - HAP) while participants in the Community Model will receive both the HAP and the community intervention. We will compare the Facility Model and the Community Model to assess if the latter is superior in increasing the demand for depression treatment in primary care, increasing uptake of treatment by people with depression, increasing treatment completion rates, and reducing the severity of depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Nov 2023
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2023
CompletedFirst Posted
Study publicly available on registry
June 6, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedApril 23, 2026
May 1, 2025
2 years
May 12, 2023
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Contact coverage
Patient Health Questionnaire 9 items (PHQ-9) score \>4. The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.
During recruitment
Effectiveness coverage
Mean Patient Health Questionnaire 9 items (PHQ-9 score). The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.
Three months post recruitment
Secondary Outcomes (14)
Sustained effectiveness
Six months post recruitment
Remission
Three months post recruitment
Remission
Six months post recruitment
Response to treatment
Three months post recruitment
Response to treatment
Six months post recruitment
- +9 more secondary outcomes
Study Arms (2)
Community Model
EXPERIMENTALIn addition to the facility model, village clusters in this arm will receive community intervention strategies delivered by community volunteers.
Facility Model
ACTIVE COMPARATORThe HAP, a manualized and evidence-based psychological treatment based on behavioural activation, will be delivered by existing healthcare workers (called counsellors from here onwards) within the health centres who will be trained to deliver the HAP.
Interventions
Community intervention strategies will be delivered by community volunteers (called Sangathis - which means companion in Konkani, one of the local languages) to i) enhance demand for the HAP treatment and ii) promote engagement with, and completion of, the HAP treatment. The community intervention is co-produced with local community members and includes strategies such as activities to increase awareness about depression (community meetings, street plays and health camps), and dissemination of psycho-educational materials (i.e., leaflets and posters), identify people with possible depression in the community, and facilitate access to HAP in the health centres. Additionally, the Sangathis will coordinate continuing care of people receiving HAP, through home visits to encourage behavioural activation, homework completion and following up with the counsellor, and engaging family members to support the patient in achieving treatment goals.
HAP includes the following strategies: psychoeducation, behavioural assessment, activity monitoring, activity structuring and scheduling, activation of social networks, and problem-solving. HAP will be delivered in an individual format. It entails three phases of treatment, delivered over six to eight sessions, each lasting up to 40 minutes, with the sessions being at weekly intervals. Sessions will be delivered face-to-face, at the health centre where the counsellors already work.
Eligibility Criteria
You may qualify if:
- Adults (\>18 years)
- Residing in the clusters included in the trial
- Speak English or one of the local languages (Konkani, Marathi, Hindi)
You may not qualify if:
- Patients with significant speech, hearing, or language impairment that interferes with completion of the screening and/or receipt of psychosocial intervention
- Patients who present to the health centre for emergency medical attention
- Patients with active psychotic symptoms
- (B) Effectiveness Coverage Outcome
- Adults (\>18 years);
- Residing in the clusters included in the trial
- Speak English or one of the local languages (Konkani, Marathi, Hindi).
- Screen positive for moderately severe or severe depression (total score \>14) on the Patient Health Questionnaire-9 items (PHQ-9)
- Patients with significant speech, hearing, or language impairment that interferes with completion of the screening and/or receipt of psychosocial intervention
- Patients who present to the health centre for emergency medical attention
- Patients with active psychotic symptoms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sangathlead
- London School of Hygiene and Tropical Medicinecollaborator
- Harvard Medical School (HMS and HSDM)collaborator
- Centre for Addiction and Mental Healthcollaborator
Study Sites (1)
Sangath
Mormugao, Goa, India
Related Publications (1)
Nadkarni A, Gandhi Y, Fernandes L, Mirchandani K, Kamat S, Weiss HA, Singla DR, Velleman R, Lu C, Bhatia U, Biswal B, Sequeira M, D'souza E, Raikar K, Patel V. Effectiveness and cost-effectiveness of a community intervention in enhancing access to care and improving clinical outcomes for depression: a protocol for a cluster randomised controlled trial in India. Trials. 2024 Aug 28;25(1):569. doi: 10.1186/s13063-024-08236-0.
PMID: 39198915DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2023
First Posted
June 6, 2023
Study Start
November 1, 2023
Primary Completion
November 18, 2025
Study Completion
April 30, 2026
Last Updated
April 23, 2026
Record last verified: 2025-05